24 results on '"Yassine, Hadi M."'
Search Results
2. Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient
3. Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting
4. Seroprevalence of hepatitis E virus (HEV) among male craft and manual workers in Qatar (2020–2021)
5. Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months
6. Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
7. Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
8. Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study
9. Enhancing the sensitivity of rapid antigen detection test (RADT) of different SARS-CoV-2 variants and lineages using fluorescence-labeled antibodies and a fluorescent meter
10. Influenza prevalence and vaccine efficacy among diabetic patients in Qatar
11. Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis
12. Molecular epidemiology, genetic diversity, and vaccine availability of viral acute gastroenteritis in the middle East and North Africa (MENA) region
13. Will influenza A(H3N8) cause a major public health threat?
14. Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients
15. Human herpes simplex virus-6 (HHV-6) detection and seroprevalence among Qatari nationals and immigrants residing in Qatar
16. Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection
17. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
18. Seroprevalence of West Nile Virus among Healthy Blood Donors from Different National Populations Residing in Qatar
19. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
20. Molecular epidemiology of influenza, RSV, and other respiratory infections among children in Qatar: A six years report (2012–2017)
21. Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
22. BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescents
23. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.
24. Human herpes simplex virus-6 (HHV-6) detection and seroprevalence among Qatari nationals and immigrants residing in Qatar.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.